跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
NEUPRO rotigotine 8 mg/24 hr transdermal patch sachet
Approved
STANDARD
NEUPRO rotigotine 8 mg/24 hr transdermal patch sachet
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7a88cf315c5834ba
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
7a88cf315c5834ba
Product Name
NEUPRO rotigotine 8 mg/24 hr transdermal patch sachet
Artg Id
131383
Artg Name
NEUPRO rotigotine 8 mg/24hr transdermal patch sachet
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2007-11-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/25ba3a58ef4ebe4da81edcf01294ccd1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b7ce8172046353f81632db7455a100a0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7a88cf315c5834ba
Type
Standard
Back to TGA Approvals
NEUPRO rotigotine 8 mg/24 hr transdermal patch sachet - TGA Drug Approval Details
